Acarix AB (publ) (ACIXF)

Market Cap	42.49M +82.4%
Revenue (ttm)	734.28K +21.9%
Net Income	-5.57M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	40,764
Open	0.0330
Previous Close	0.0330
Day's Range	0.0330 - 0.0330
52-Week Range	0.0090 - 0.0459
Beta	-0.30
RSI	51.42
Earnings Date	Feb 12, 2026

About Acarix AB

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 8
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACIXF

Financial Performance

In 2024, Acarix AB's revenue was 6.20 million, a decrease of -0.62% compared to the previous year's 6.24 million. Losses were -66.19 million, -14.97% less than in 2023.

Financial numbers in SEK